Elpro International Limited (BOM:504000)
India · Delayed Price · Currency is INR 94.27
-2.28 (-2.36%)
At close: Aug 1, 2025
Verve Therapeutics Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 661.11 | 854.87 | 479.37 | 10,567 | 197.41 | Upgrade |
Depreciation & Amortization | 103.69 | 53.3 | 49.01 | 48.57 | 41.38 | Upgrade |
Other Amortization | - | 0.03 | 0.03 | 0.05 | 0.06 | Upgrade |
Loss (Gain) From Sale of Investments | -511.76 | -402 | -191.49 | -12,707 | -0.23 | Upgrade |
Loss (Gain) on Equity Investments | -2.11 | -2.37 | -1.1 | 82.01 | -125.98 | Upgrade |
Stock-Based Compensation | - | - | - | 13.89 | 57.56 | Upgrade |
Other Operating Activities | 338.07 | 255.82 | 79.01 | 485.1 | 133.14 | Upgrade |
Change in Accounts Receivable | -36.51 | -76.28 | -287.02 | -131.11 | -85.56 | Upgrade |
Change in Inventory | -0.11 | 4.96 | -5.38 | -2.05 | 1.56 | Upgrade |
Change in Accounts Payable | 1,634 | -105.39 | 187.3 | 24.43 | -62.12 | Upgrade |
Change in Other Net Operating Assets | - | 5.5 | - | - | - | Upgrade |
Operating Cash Flow | 2,186 | 1,407 | -1,359 | -1,619 | 157.23 | Upgrade |
Operating Cash Flow Growth | 55.33% | - | - | - | -37.09% | Upgrade |
Capital Expenditures | -2,713 | -430.23 | -2,299 | -20.25 | -15.28 | Upgrade |
Investment in Securities | -4,692 | -2,977 | 2,415 | 3,813 | 58.06 | Upgrade |
Other Investing Activities | 158.95 | 80.81 | 105.2 | 21.15 | 32.66 | Upgrade |
Investing Cash Flow | -7,673 | -3,447 | 337.75 | 3,868 | 202.52 | Upgrade |
Long-Term Debt Issued | 6,213 | 2,378 | 849.28 | - | - | Upgrade |
Total Debt Issued | 6,213 | 2,378 | 849.28 | - | - | Upgrade |
Long-Term Debt Repaid | - | - | - | -1,663 | -121.41 | Upgrade |
Total Debt Repaid | - | - | - | -1,663 | -121.41 | Upgrade |
Net Debt Issued (Repaid) | 6,213 | 2,378 | 849.28 | -1,663 | -121.41 | Upgrade |
Common Dividends Paid | -118.64 | -140.67 | - | - | - | Upgrade |
Other Financing Activities | -616.48 | -212.83 | -26.44 | -187.33 | -208.03 | Upgrade |
Financing Cash Flow | 5,478 | 2,025 | 602.17 | -1,850 | -329.44 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | 21.82 | - | - | - | Upgrade |
Net Cash Flow | -9.36 | 7.07 | -418.93 | 398.22 | 30.32 | Upgrade |
Free Cash Flow | -526.75 | 977.02 | -3,658 | -1,640 | 141.95 | Upgrade |
Free Cash Flow Margin | -11.43% | 34.10% | -241.13% | -12.19% | 21.37% | Upgrade |
Free Cash Flow Per Share | -3.11 | 5.76 | -21.59 | -9.67 | 0.84 | Upgrade |
Cash Interest Paid | 616.48 | 212.83 | 26.44 | 187.33 | 208.03 | Upgrade |
Cash Income Tax Paid | - | 110.04 | 64.38 | 1,854 | 37.81 | Upgrade |
Levered Free Cash Flow | -2,173 | 78.52 | -1,811 | 8,029 | 131.59 | Upgrade |
Unlevered Free Cash Flow | -1,752 | 235.51 | -1,783 | 8,152 | 272.73 | Upgrade |
Change in Net Working Capital | 26.51 | 212.25 | -35.8 | 33.3 | -4.51 | Upgrade |
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.